Rituximab affects the B-cell lineage; it is an antibody directed at CD20. Rituximab is given as an intravenous infusion – two infusions, each lasting approximately 4–5 h, 2 weeks apart.

Rituxan (rituximab) is a brand-name intravenous (IV) infusion drug that’s prescribed for rheumatoid arthritis (RA) and other conditions. The side effects you experience may vary depending on the ...

Therapy for inflammatory joint diseases, such as rheumatoid arthritis, ankylosing spondylitis ... Rare/serious toxicities Abatacept (Orencia®) Infusion reactions, headaches, upper respiratory ...

Non-pharmacological interventions play a big role in managing rheumatoid arthritis (RA) symptoms and improving quality of ...

as they tend to be more cost-effective owing to a lack of infusion administration fee. Bongartz, T. et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and ...

Although rheumatoid arthritis is an autoimmune disease with no cure, a tailored, multidisciplinary treatment approach at Cedars-Sinai's Inflammatory Arthritis Clinical Center helps patients get back ...

Individuals with rheumatoid arthritis face a higher risk of hospitalization for heart failure and pulmonary edema, a new ...

Private equity-backed IVX Health is expanding its infusion and injection therapy locations with six new NJ retail spots ...